NEW YORK (
) is trading at unusually high volume Friday with 481,241 shares changing hands. It is currently at four times its average daily volume and trading up $1.94 (+9.7%) at $21.89 as of 2:40 p.m. ET.
Genomic Health has a market cap of $576.3 million and is part of the
industry. Shares are down 6.7% year to date as of the close of trading on Thursday.
Genomic Health, Inc., a molecular diagnostics company, focuses on the development and global commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. The company has a P/E ratio of 75.2, below the average health services industry P/E ratio of 81.4 and above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Genomic Health as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and impressive record of earnings per share growth. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. You can view the full
See all heavy volume stocks in our
or get investment ideas from our
Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting
to 95370 or select from